These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

76 related items for PubMed ID: 7634353

  • 1. Dissection of cross-reactivities using a panel of H-2Ld alloreactive T cell hybridomas.
    Killion CC, Chen PJ, Dadgari JM, McMillan M.
    Cell Immunol; 1995 Aug; 164(1):81-9. PubMed ID: 7634353
    [Abstract] [Full Text] [Related]

  • 2. Biased T cell receptor usage by Ld-restricted, tum- peptide-specific cytotoxic T lymphocyte clones.
    Solheim JC, Alexander-Miller MA, Martinko JM, Connolly JM.
    J Immunol; 1993 Feb 01; 150(3):800-11. PubMed ID: 8380825
    [Abstract] [Full Text] [Related]

  • 3. Alloreactive cytotoxic T lymphocytes generated in the presence of viral-derived peptides show exquisite peptide and MHC specificity.
    Alexander-Miller MA, Burke K, Koszinowski UH, Hansen TH, Connolly JM.
    J Immunol; 1993 Jul 01; 151(1):1-10. PubMed ID: 8392095
    [Abstract] [Full Text] [Related]

  • 4. The allorecognition of H-2Kb-specific CD4-CD8- T cell hybridomas is influenced by the substitution at residue 256 of MHC class I molecules.
    Tanabe M, Minami M, Kano K, Takiguchi M.
    J Immunol; 1990 Sep 15; 145(6):1968-73. PubMed ID: 2118159
    [Abstract] [Full Text] [Related]

  • 5. Alloreactive and syngeneic CTL are comparably dependent on interaction with MHC class I alpha-helical residues.
    Hornell TM, Solheim JC, Myers NB, Gillanders WE, Balendiran GK, Hansen TH, Connolly JM.
    J Immunol; 1999 Sep 15; 163(6):3217-25. PubMed ID: 10477590
    [Abstract] [Full Text] [Related]

  • 6. Peptides control the gain and loss of allele specificity by mutated MHC class I molecules.
    Hengel H, Burke K, Kyburz D, Zinkernagel RM, Koszinowski UH.
    J Immunol; 1995 May 01; 154(9):4557-64. PubMed ID: 7722309
    [Abstract] [Full Text] [Related]

  • 7. Reactivity of hybridomas derived from T cells activated in vivo during graft-versus-host disease.
    Leibnitz RR, Lipsky PE, Thiele DL.
    J Immunol; 1994 Dec 01; 153(11):4959-68. PubMed ID: 7963559
    [Abstract] [Full Text] [Related]

  • 8. Binding of peptides lacking consensus anchor residue alters H-2Ld serologic recognition.
    Solheim JC, Carreno BM, Smith JD, Gorka J, Myers NB, Wen Z, Martinko JM, Lee DR, Hansen TH.
    J Immunol; 1993 Nov 15; 151(10):5387-97. PubMed ID: 7693810
    [Abstract] [Full Text] [Related]

  • 9. Cytotoxic T lymphocytes from mice with soluble class I Q10 molecules in their serum are not tolerant to membrane-bound Q10.
    Mann DW, Stroynowski I, Hood L, Forman J.
    J Immunol; 1987 Jan 01; 138(1):240-5. PubMed ID: 3491158
    [Abstract] [Full Text] [Related]

  • 10. Preferential V beta usage by cytotoxic T cells cross-reactive between two epitopes of HIV-1 gp160 and degenerate in class I MHC restriction.
    Shirai M, Vacchio MS, Hodes RJ, Berzofsky JA.
    J Immunol; 1993 Aug 15; 151(4):2283-95. PubMed ID: 7688397
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Direct evidence for in vivo induction of CD8+ cytotoxic T cells directed to donor MHC class I peptides following mouse allotransplantation.
    Popov IA, Fedoseyeva EV, Orr PL, Garovoy MR, Benichou G.
    Transplantation; 1995 Dec 27; 60(12):1621-4. PubMed ID: 8545902
    [Abstract] [Full Text] [Related]

  • 13. H-2Ld-alloreactive T cell hybridomas utilize diverse V alpha and V beta T cell receptor chains.
    Louie KA, Ochoa-Garay J, Chen PJ, McKinney D, Groshen S, McMillan M.
    Mol Immunol; 1996 Jun 27; 33(9):747-58. PubMed ID: 8811070
    [Abstract] [Full Text] [Related]

  • 14. An H-2Ld hybrid molecule with a Qa-2 alpha-3 domain and phosphatidyl-inositol anchor is not recognized by H-2Ld-specific cytotoxic T lymphocytes.
    Mann DW, Stroynowski I, Hood L, Forman J.
    J Immunol; 1989 Jan 01; 142(1):318-22. PubMed ID: 2462590
    [Abstract] [Full Text] [Related]

  • 15. Cross-reactive T cell clones from unrelated individuals reveal similarities in peptide presentation between HLA-B27 and HLA-DR2.
    López D, Barber DF, Villadangos JA, López de Castro JA.
    J Immunol; 1993 Apr 01; 150(7):2675-86. PubMed ID: 7681078
    [Abstract] [Full Text] [Related]

  • 16. Reciprocal cytotoxic T lymphocyte cross-reactivity interactions between two major epitopes within HIV-1 gp160.
    Shirai M, Kurokohchi K, Pendleton CD, Arichi T, Boyd LF, Takahashi H, Margulies DH, Berzofsky JA.
    J Immunol; 1996 Nov 15; 157(10):4399-411. PubMed ID: 8906815
    [Abstract] [Full Text] [Related]

  • 17. A molecular basis for how a single TCR interfaces multiple ligands.
    Boesteanu A, Brehm M, Mylin LM, Christianson GJ, Tevethia SS, Roopenian DC, Joyce S.
    J Immunol; 1998 Nov 01; 161(9):4719-27. PubMed ID: 9794402
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. An immunodominant epitope present in multiple class I MHC molecules and recognized by cytotoxic T lymphocytes.
    Mann DW, McLaughlin-Taylor E, Wallace RB, Forman J.
    J Exp Med; 1988 Jul 01; 168(1):307-24. PubMed ID: 2456370
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.